{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:46:16Z","timestamp":1792593976255,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1124\/jpet.115.226100","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T01:59:37Z","timestamp":1439517577000},"page":"66-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid"],"prefix":"10.1016","volume":"355","author":[{"given":"Christeene G.","family":"Haj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Percy F.","family":"Sumariwalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lum\u00edr","family":"Hanu\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya M.","family":"Kogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhana","family":"Yektin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Mechoulam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Gallily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.115.226100_bib1","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1476-5381.2010.01179.x","article-title":"Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice","volume":"162","author":"Avraham","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.115.226100_bib2","doi-asserted-by":"crossref","first-page":"9902","DOI":"10.1074\/jbc.271.17.9902","article-title":"(-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase","volume":"271","author":"Bayewitch","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.115.226100_bib3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1021\/jm050709m","article-title":"New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity","volume":"49","author":"Ben-Shabat","year":"2006","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.115.226100_bib4","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.115.226100_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(03)00569-X","article-title":"Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils","volume":"346","author":"Braida","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.115.226100_bib6","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1021\/jm00095a007","article-title":"Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities","volume":"35","author":"Burstein","year":"1992","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.115.226100_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of cannabidiol to healthy volunteers and epileptic patients","volume":"21","author":"Cunha","year":"1980","journal-title":"Pharmacology"},{"key":"10.1124\/jpet.115.226100_bib8","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1021\/jm00089a018","article-title":"A novel probe for the cannabinoid receptor","volume":"35","author":"Devane","year":"1992","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.115.226100_bib9","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1124\/jpet.115.226100_bib10","doi-asserted-by":"crossref","first-page":"H3602","DOI":"10.1152\/ajpheart.00098.2007","article-title":"Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury","volume":"293","author":"Durst","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.115.226100_bib11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1749-6632.1995.tb26675.x","article-title":"TNF alpha is an effective therapeutic target for rheumatoid arthritis","volume":"766","author":"Feldmann","year":"1995","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 1","key":"10.1124\/jpet.115.226100_bib12","doi-asserted-by":"crossref","first-page":"i97","DOI":"10.1136\/ard.2009.117143","article-title":"What have we learnt from targeted anti-TNF therapy?","volume":"69","author":"Feldmann","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1124\/jpet.115.226100_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.2012.04341.x","article-title":"Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?","volume":"75","author":"Fern\u00e1ndez-Ruiz","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.115.226100_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(93)90468-W","article-title":"Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent","volume":"231","author":"Fride","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.115.226100_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar2631","article-title":"The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus","volume":"11","author":"Full","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1124\/jpet.115.226100_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/ja00730a036","article-title":"The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish","volume":"93","author":"Gaoni","year":"1971","journal-title":"J Am Chem Soc"},{"key":"10.1124\/jpet.115.226100_bib17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.2000.tb06193.x","article-title":"Neuroprotective antioxidants from marijuana","volume":"899","author":"Hampson","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.115.226100_bib18","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1471-4159.2007.04565.x","article-title":"Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism","volume":"102","author":"Hayakawa","year":"2007","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.115.226100_bib19","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1021\/jo01070a009","article-title":"Study of the chromium (VI) oxide-pyridine complex","volume":"26","author":"Holum","year":"1961","journal-title":"J Org Chem"},{"key":"10.1124\/jpet.115.226100_bib20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1476-5381.2010.00791.x","article-title":"The effects of \u0394-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis","volume":"160","author":"Jamontt","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.115.226100_bib21","doi-asserted-by":"crossref","unstructured":"Kozela E, Haj C, Hanu\u0161 L, Chourasia M, Shurki A, Juknat A, Kaushansky N, Mechoulam R, Vogel Z (2015) HU-446 and HU-465, derivatives of the non-psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells. Chem Biol Drug Des, in press.","DOI":"10.1111\/cbdd.12637"},{"key":"10.1124\/jpet.115.226100_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.115.226100_bib23","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/eji.1830271119","article-title":"In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis","volume":"27","author":"K\u00fcsters","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1124\/jpet.115.226100_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1039\/P19760000008","article-title":"Total synthesis of cannabidiol and \u22061-THC metabolites","volume":"1","author":"Lander","year":"1976","journal-title":"J Chem Soc Perkin Trans"},{"key":"10.1124\/jpet.115.226100_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2004.11.009","article-title":"Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson\u2019s disease","volume":"19","author":"Lastres-Becker","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.115.226100_bib26","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1124\/jpet.115.226100_bib27","doi-asserted-by":"crossref","first-page":"9561","DOI":"10.1073\/pnas.160105897","article-title":"The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis","volume":"97","author":"Malfait","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.115.226100_bib28","first-page":"540","article-title":"Medical marijuana","volume":"168","author":"Marmor","year":"1998","journal-title":"West J Med"},{"key":"10.1124\/jpet.115.226100_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(91)90349-7","article-title":"Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs","volume":"40","author":"Martin","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.115.226100_bib30","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer\u2019s disease","volume":"79","author":"Mart\u00edn-Moreno","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.115.226100_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.2012.04298.x","article-title":"Cannabidiol as potential anticancer drug","volume":"75","author":"Massi","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.115.226100_bib32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrn3811","article-title":"Early phytocannabinoid chemistry to endocannabinoids and beyond","volume":"15","author":"Mechoulam","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.115.226100_bib33","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.115.226100_bib34","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol: recent advances","volume":"4","author":"Mechoulam","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1124\/jpet.115.226100_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11101-004-1534-1","article-title":"Cannabinoids in models of chronic inflammatory conditions","volume":"4","author":"Mechoulam","year":"2005","journal-title":"Phytochem Rev"},{"key":"10.1124\/jpet.115.226100_bib36","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"10.1124\/jpet.115.226100_bib37","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neuropharm.2012.05.034","article-title":"Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function","volume":"63","author":"Pazos","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.115.226100_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00397918508076823","article-title":"An improved procedure for the synthesis of oleuropeic acid","volume":"15","author":"Pellegata","year":"1986","journal-title":"Synth Commun"},{"key":"10.1124\/jpet.115.226100_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/3-540-26573-2_1","article-title":"Pharmacological actions of cannabinoids","volume":"168","author":"Pertwee","year":"2005","journal-title":"Handbook Exp Pharmacol"},{"key":"10.1124\/jpet.115.226100_bib40","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.yebeh.2013.08.037","article-title":"Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy","volume":"29","author":"Porter","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1124\/jpet.115.226100_bib41","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1021\/jo00836a108","article-title":"Improved procedure for oxidations with the chromium trioxide-pyridine complex","volume":"35","author":"Ratcliffe","year":"1970","journal-title":"J Org Chem"},{"key":"10.1124\/jpet.115.226100_bib42","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1476-5381.2011.01621.x","article-title":"Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus","volume":"165","author":"Rock","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.115.226100_bib43","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1021\/ja00775a050","article-title":"Selenium dioxide oxidation of olefins: evidence for the intermediacy of allylselenic acids","volume":"94","author":"Sharpless","year":"1972","journal-title":"J Am Chem Soc"},{"key":"10.1124\/jpet.115.226100_bib44","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1021\/jo00393a045","article-title":"Mechanism of allylic hydroxylation by selenium dioxide","volume":"44","author":"Stephenson","year":"1979","journal-title":"J Org Chem"},{"key":"10.1124\/jpet.115.226100_bib45","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/ar608","article-title":"The angiogenesis inhibitor protease-activated kringles 1-5 reduces the severity of murine collagen-induced arthritis","volume":"5","author":"Sumariwalla","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1124\/jpet.115.226100_bib46","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/art.20050","article-title":"A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis","volume":"50","author":"Sumariwalla","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.115.226100_bib47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s40265-014-0197-5","article-title":"Delta-9-tetrahydrocannabinol\/cannabidiol (Sativex\u00ae): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis","volume":"74","author":"Syed","year":"2014","journal-title":"Drugs"},{"key":"10.1124\/jpet.115.226100_bib48","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0952-7915(00)00269-7","article-title":"Immunotherapy for rheumatoid arthritis","volume":"13","author":"Taylor","year":"2001","journal-title":"Curr Opin Immunol"},{"key":"10.1124\/jpet.115.226100_bib49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.115.226100_bib50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2007.06.029","article-title":"Cannabidiol arrests onset of autoimmune diabetes in NOD mice","volume":"54","author":"Weiss","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.115.226100_bib51","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1365-2249.1998.00785.x","article-title":"Rodent models of arthritis: relevance for human disease","volume":"114","author":"Williams","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1124\/jpet.115.226100_bib52","first-page":"207","article-title":"Collagen-induced arthritis as a model for rheumatoid arthritis","volume":"98","author":"Williams","year":"2004","journal-title":"Methods Mol Med"},{"key":"10.1124\/jpet.115.226100_bib53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-59745-402-5_14","article-title":"Collagen-induced arthritis in mice","volume":"136","author":"Williams","year":"2007","journal-title":"Methods Mol Med"},{"key":"10.1124\/jpet.115.226100_bib54","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/ph5050529","article-title":"Cannabidiol in humans: the quest for therapeutic targets","volume":"5","author":"Zhornitsky","year":"2012","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1124\/jpet.115.226100_bib55","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jcb.10291","article-title":"Prospects for cannabinoids as anti-inflammatory agents","volume":"88","author":"Zurier","year":"2003","journal-title":"J Cell Biochem"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652419132X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652419132X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.115.226100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:36:13Z","timestamp":1739993773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652419132X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S002235652419132X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.115.226100","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.115.226100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}